Kronox Lab Sciences Ltd
Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Number of Products Sold / Portfolio Size Numbers ・Standalone data |
|
||||
| Total Installed Capacity TPA ・Standalone data |
|||||
| Number of Customers Served Numbers ・Standalone data |
|||||
| Products Under Development Numbers ・Standalone data |
|||||
| Average Capacity Utilization % ・Standalone data |
|||||
| Total Production Volume TPA ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
2d - Submitted Annual Secretarial Compliance Report for FY ended March 31, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
24 May - Newapaper publication for Audited Financial Results for the Quarter and Year ended March 31, 2026
-
Audited Standalone Financial Results For The Quarter And Year Ended On March 31, 2026
21 May - Kronox Lab Sciences announced Q4 and FY26 audited results, 5% final dividend, and unmodified audit opinion.
- Board Meeting Outcome for Outcome Of Board Meeting 21 May
-
Board Meeting Intimation for Consider And Approve Audited Standalone Financial Results For The Quarter And Year Ended March 31, 2026
18 May - Board meets on 21 May 2026 to approve audited FY26 results and consider dividend.
Business Overview:[1][2]
KLSL is in High Purity Speciality Fine Chemicals Business with portfolio of about 185 products including Excipients and ingredients, High Purity Reagents, Pharmaceutical, nutraceutical and Food Chemical.